Research Article: Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice
Introduction:
Obesity is a major public health problem because it raises the risk of death from cardiovascular disease, diabetes, and non-alcoholic fatty liver disease (NAFLD). – NAFLD is a cause of chronic liver disease that is frequently overlooked despite its worldwide prevalence due to the buildup of hepatic fatty acids and fibrosis without excessive alcohol use. In addition to nonalcoholic steatohepatitis (NASH), nonalcoholic fatty liver (NAFL) is another significant subtype of NAFLD. The estimated prevalence of NAFLD…
Read more